Bacterial Identification and Susceptibility Testing

Identifying which bacterium is causing an infection—and knowing which antibiotics will actually kill it—are two of the most consequential tasks in clinical medicine, because the wrong empirical treatment can cost a patient hours they don't have. MALDI-TOF mass spectrometry has transformed this process by matching a bacterium's protein fingerprint against a reference library in minutes rather than the days required by traditional culture-based methods, and it has become a central tool for diagnosing bloodstream infections where speed is especially critical. Current research is pushing further toward direct testing from blood without prior culture, shrinking the diagnostic window even more, while also integrating rapid susceptibility data so that clinicians receive actionable resistance profiles rather than a species name alone. Open questions center on expanding reference databases to cover rare and emerging pathogens reliably and on determining how best to embed these faster diagnostics into stewardship programs that actually change prescribing behavior.

Works

68,524

Total citations

736,642

Keywords

Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass SpectrometryMicroorganism IdentificationClinical MicrobiologyBlood CultureAntimicrobial Susceptibility TestingBacterial Identification